Literature DB >> 7715749

[Strategies for early admission of stroke patients].

B Müffelmann1, J Glahn, S Kunz, O Busse.   

Abstract

From March to August 1993 we performed a comprehensive educational campaign about stroke and acute stroke therapies to shorten admission delay and to recruit more patients for the ECASS trial [8]. We compared the presentation data of all stroke patients admitted in a six month preeducational period with data of a six month posteducational period. The median admission delay was significantly reduced from eight hours in the preeducational to five hours in the posteducational period. The number of patients undergoing thrombolytic treatment increased. The following factors shortened admission delay: age > 70 years, living in cities, stroke onset during daytime, admission by ambulance, stroke in anterior circulation, cardiogenic embolic stroke, severe symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 7715749

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  4 in total

1.  [Symptoms, risk factors, and etiology of transient ischemic attack and stroke].

Authors:  C H Nolte; J Müller-Nordhorn; G J Jungehülsing; K Rossnagel; A Reich; M Klein; S N Willich; A Villringer
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

2.  [Stroke. Public knowledge and information sources].

Authors:  R Handschu; E Babjar; M Reitmayer; J G Heckmann; F Erbguth; B Neundörfer
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

3.  [Causes of a prolonged prehospital phase in patients admitted to a stroke unit. Can it be influenced by campaigns to educate the public?].

Authors:  N K Schmidt; J Hüwel; B Weisner
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

Review 4.  Stroke warning campaigns: delivering better patient outcomes? A systematic review.

Authors:  Lisa Mellon; Frank Doyle; Daniela Rohde; David Williams; Anne Hickey
Journal:  Patient Relat Outcome Meas       Date:  2015-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.